Cincinnati claims reliever was injured before trade

CINCINNATI -- The Reds have filed a grievance against the
Washington Nationals over the trade that brought sore-shouldered
reliever Gary Majewski to Cincinnati last season.

The Reds contend that Nationals general manager Jim Bowden
failed to inform them of Majewski's shoulder problems when they got
the right-hander as part of an eight-player deal last July 13.

Majewski has struggled since joining the Reds, and is in the
minors this season.

Major League Baseball spokesman Patrick Courtney confirmed the
grievance on Saturday. Baseball officials will gather information
about the disputed deal, and could decide to let it stand or force
the teams to amend it.

There is no timetable for resolving the dispute, which has been
simmering since last August. Reds general manager Wayne Krivsky
declined to comment on Saturday.

Bowden declined to speak with reporters before Washington's game
Saturday night against Baltimore.

The Nationals received shortstop Felipe Lopez and outfielder
Austin Kearns, two of the Reds' regulars.

Majewski and left-handed reliever Bill Bray were keys to the
deal for Cincinnati, which desperately needed help in its bullpen.
Majewski did poorly when he arrived in Cincinnati, compiling a
12.54 ERA in 11 appearances.

Majewski went on the disabled list on Aug. 7 after telling the
team that his shoulder had bothered him all season and that he got
a cortisone shot before the All-Star break. Krivsky has said that
the Nationals didn't mention the cortisone shot when they were
negotiating the trade.

Bowden, a former Cincinnati GM, has said the Reds received all
the information that they requested.

The Reds have been considering a grievance since they learned of
the cortisone shot. Majewski returned at the end of last season and
had a 1.59 ERA in eight appearances.

His problems returned this spring, when weakness in the shoulder
limited him to two appearances. Majewski has gone 1-1 with a 5.54
ERA in 13 appearances for Triple-A Louisville this season.